aTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is efzofitimod (ATYR1923), a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in severe inflammatory lung diseases. For more information, please visit http://www.atyrpharma.com.
The Company was founded by Professors Paul Schimmel, Ph.D., and Xiang-Lei Yang, Ph.D., two leading aminoacyl tRNA synthetase scientists at The Scripps Research Institute.
Company Details
- Employees
- 81
- Address
- 10240 Sorrento Valley Rd,
- Phone
- (858) 731-8389
- me****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- atyrpharma.com
- HQ
- San Diego, California
Atyr Pharma Questions
Atyr Pharma's helpline number is (858) 731-8389
Atyr Pharma's website is atyrpharma.com
Atyr Pharma's LinkedIn profile is https://www.linkedin.com/company/atyr-pharma
Atyr Pharma has
81 employees.
View email and phone details for 81
employees at Atyr Pharma.
Atyr Pharma's industry is
Biotechnology Research
Atyr Pharma's support email address is media@atyrpharma.com
Atyr Pharma's categories are Biotechnology Research
